Adenoviral-mediated transfer of Escherichia coli uracil phosphoribosyltransferase (UPRT) gene to modulate the sensitivity of the human colon cancer cells to 5-fluorouracil
- 31 December 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (18) , 2403-2410
- https://doi.org/10.1016/s0959-8049(00)00338-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal CancersOncology, 1999
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- Circumvention of 5‐Fluorouracil Resistance in Human Stomach Cancer Cells by Uracil Phosphoribosyltransferase Gene TransductionJapanese Journal of Cancer Research, 1999
- Adjuvant therapy for colorectal cancerDiseases of the Colon & Rectum, 1997
- Phase I Study of Direct Administration of a Replication Deficient Adenovirus Vector Containing theE. coliCytosine Deaminase Gene to Metastatic Colon Carcinoma of the Liver in Association with the Oral Administration of the Pro-Drug 5-Fluorocytosine. The New York Hospital-Cornell Medical Center, New York, NYHuman Gene Therapy, 1997
- Tumor-specific gene expression in carcinoembryonic antigen--producing gastric cancer cells using adenovirus vectorsGastroenterology, 1996
- In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-FluorocytosineHuman Gene Therapy, 1995
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal Of Cancer, 1994
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- Plasma CEA, tumor CEA, and tumor histologyJournal of Surgical Oncology, 1976